Charles River Laboratories International (CRL) Equity Income (2016)
Historic Equity Income for Charles River Laboratories International (CRL) over the last 5 years, with Q3 2016 value amounting to $442000.0.
- Charles River Laboratories International's Equity Income fell 8635.8% to $442000.0 in Q3 2016 from the same period last year, while for Sep 2016 it was $8.7 million, marking a year-over-year increase of 5804.99%. This contributed to the annual value of $3.8 million for FY2015, which is 5889.69% down from last year.
- Latest data reveals that Charles River Laboratories International reported Equity Income of $442000.0 as of Q3 2016, which was down 8635.8% from $5.0 million recorded in Q2 2016.
- Charles River Laboratories International's 5-year Equity Income high stood at $6.1 million for Q1 2014, and its period low was -$907000.0 during Q2 2015.
- Its 5-year average for Equity Income is $1.4 million, with a median of $1.1 million in 2013.
- As far as peak fluctuations go, Charles River Laboratories International's Equity Income surged by 688222.22% in 2014, and later plummeted by 14368.98% in 2015.
- Charles River Laboratories International's Equity Income (Quarter) stood at -$373000.0 in 2012, then skyrocketed by 386.33% to $1.1 million in 2013, then skyrocketed by 80.15% to $1.9 million in 2014, then crashed by 88.62% to $219000.0 in 2015, then skyrocketed by 101.83% to $442000.0 in 2016.
- Its Equity Income was $442000.0 in Q3 2016, compared to $5.0 million in Q2 2016 and $3.1 million in Q1 2016.